Tweet
First time uploading to Basespace. Only generated FastQ's at first but now want to align it. There doesn't seem to be an option. Is it even possible?
-
-
Currently runs cannot be requeued for analysis, I have to rerun analysis using MiSeq reporter locally. You can also ask nicely and see if a dev will alter sample sheet for your chosen application and requeue analysis. I hope they allow rerunning analysis soon, if you have an error with your sample sheet you have to get Illumina devs to fix and restart analysis or have a forever "failed" run in BaseSpace. -
Yep, that's what I figured. Not a huge deal but kind of annoying. The main point of BaseSpace is to be able to manipulate data in the cloud. I guess I can't get too angry because it is still in beta testing, and it looks like this kind of thing will be available when they roll out the app store ~ the end of Nov it seems.
Thanks for the reply epistatic.Last edited by yoyoming1001; 10-14-2012, 12:09 PM.Comment
-
Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...Today, 01:13 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment